UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives

European journal of medicinal chemistry, 2016-02, Vol.109, p.314-341

2016

Volltextzugriff (PDF)

PIM kinase inhibitors: Structural and pharmacological perspectives

European journal of medicinal chemistry, 2019-06, Vol.172, p.95-108

2019

Volltextzugriff (PDF)

Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy

1, 2024

Volltextzugriff (PDF)

Chalcone Derivatives: Anti-inflammatory Potential and Molecular Targets Perspectives

Current topics in medicinal chemistry, 2017-11, Vol.17 (28), p.3146-3169

2017

Volltextzugriff (PDF)

1,3,4-Oxadiazoles: An emerging scaffold to target growth factors, enzymes and kinases as anticancer agents

European journal of medicinal chemistry, 2015-06, Vol.97, p.124-141

2015

Volltextzugriff (PDF)

Structural Perspectives in the Development of Novel EGFR Inhibitors for the Treatment of NSCLC

Mini reviews in medicinal chemistry, 2024-01, Vol.24 (19), p.1746-1783

2024

Volltextzugriff (PDF)

K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectives

European journal of medicinal chemistry, 2017-01, Vol.125, p.299-314

2017

Volltextzugriff (PDF)

Structural Aspects of mTOR Inhibitors: Search for Potential Compounds

Anti-cancer agents in medicinal chemistry, 2022-04, Vol.22 (6), p.1037-1055

2022

Volltextzugriff (PDF)

Recent Advances in the Treatment and Management of Alzheimer's Disease: A Precision Medicine Perspective

Current topics in medicinal chemistry, 2024-01, Vol.24 (19), p.1699-1737

2024

Volltextzugriff (PDF)

An exhaustive perspective on structural insights of SGLT2 inhibitors: A novel class of antidiabetic agent

European journal of medicinal chemistry, 2020-10, Vol.204, p.112523-112523, Article 112523

2020

Volltextzugriff (PDF)

Recent Advances in PI3 Kinase Inhibitors: Anticancer Activities and Structure-Activity Relationships

Mini reviews in medicinal chemistry, 2022-01, Vol.22 (16), p.2146-2165

2022

Volltextzugriff (PDF)

A Mini-review on Recent Strategies and Applications of Nanomedicines to Combat Antimicrobial Resistance

Current drug metabolism, 2023-01, Vol.24 (6), p.406-421

2023

Volltextzugriff (PDF)

Current Insights into the Chemistry and Antitubercular Potential of Benzimidazole and Imidazole Derivatives

Mini reviews in medicinal chemistry, 2021-01, Vol.21 (5), p.643-657

2021

Volltextzugriff (PDF)

Recent Updates on Structural Aspects of ALK Inhibitors as an Anticancer Agent

Anti-cancer agents in medicinal chemistry, 2023-01, Vol.23 (8), p.900-921

2023

Volltextzugriff (PDF)

The Recent Development of Piperazine and Piperidine Derivatives as Antipsychotic Agents

Mini reviews in medicinal chemistry, 2021-01, Vol.21 (3), p.362-379

2021

Volltextzugriff (PDF)

Practical Perspectives and Roles of XRD in Drug Discovery: A Review

Current analytical chemistry, 2024-01, Vol.20 (7), p.449-470

2024

Volltextzugriff (PDF)

Discovery of Novel Antimalarial Drugs Based on Thiosemicarbazone Derivatives: An In Silico Approach

Current signal transduction therapy, 2022-04, Vol.17 (1), p.59-74

2022

Volltextzugriff (PDF)

Recent Updates on Indole Derivatives as Kinase Inhibitors in the Treatment of Cancer

Anti-cancer agents in medicinal chemistry, 2023-01, Vol.23 (4), p.404-416

2023

Volltextzugriff (PDF)

Triggering PIK3CA Mutations in PI3K/Akt/mTOR Axis: Exploration of Newer Inhibitors and Rational Preventive Strategies

Current pharmaceutical design, 2016-01, Vol.22 (39), p.6039-6054

2016

Volltextzugriff (PDF)

In silico-Based Structural Prediction, Molecular Docking and ADMET Analysis of Novel Imidazo-Quinoline Derivatives as Pf Purine Nucleoside Phosphorylase Inhibitors

Current signal transduction therapy, 2023, Vol.18 (1)

2023

Volltextzugriff (PDF)

Mutant B-Raf Kinase Inhibitors as Anticancer Agents

Anti-cancer agents in medicinal chemistry, 2016-01, Vol.16 (12), p.1558-1575

2016

Volltextzugriff (PDF)

Integrated Computational Analysis on Some Indolo-quinoline Derivatives for the Development of Novel Antiplasmodium Agents: CoMFA, Pharmacophore Mapping, Molecular Docking and ADMET Studies

Current signal transduction therapy, 2022-04, Vol.17 (1), p.12-58

2022

Volltextzugriff (PDF)

Perspectives of Anti-Cancer Phytoconstituents in Pharmacotherapy

International Journal of Medical & Pharmaceutical Sciences, 2022, Vol.12 (3)

Asati, Vivek

2022

Volltextzugriff (PDF)

In silico studies on pyrazine derivatives for identifying potential inhibitors of PIM-1 kinase

Journal of applied pharmaceutical science, 2020-11

2020

Volltextzugriff (PDF)

Chalcones and their therapeutic targets for the management of diabetes: Structural and pharmacological perspectives

European journal of medicinal chemistry, 2015-03, Vol.92, p.839-865

2015

Volltextzugriff (PDF)

1 – 25 von 124

Suche als RSS-Feed

Aktive Filter

KollektionEZB Electronic Journals Library

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(59)

Publikationsform

Sprache

Englisch
(124)

Erscheinungsjahr

n.n

Thema

Science & Technology
(65)
Life Sciences & Biomedicine
(47)
Pharmacology & Pharmacy
(37)
Chemistry, Medicinal
(34)
Chemistry
(24)
Physical Sciences
(24)
Humans
(23)
Antineoplastic Agents - Pharmacology
(13)
Cancer
(12)
Antineoplastic Agents - Chemistry
(11)
Biochemistry & Molecular Biology
(11)
Docking
(11)
Chemistry, Physical
(9)
Neoplasms - Drug Therapy
(9)
Sar
(9)
Structure-Activity Relationship
(9)
Animals
(8)
Inhibitors
(8)
Virtual Screening
(8)
3d-Qsar
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives

PIM kinase inhibitors: Structural and pharmacological perspectives

Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy

Chalcone Derivatives: Anti-inflammatory Potential and Molecular Targets Perspectives

1,3,4-Oxadiazoles: An emerging scaffold to target growth factors, enzymes and kinases as anticancer agents

Structural Perspectives in the Development of Novel EGFR Inhibitors for the Treatment of NSCLC

K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectives

Structural Aspects of mTOR Inhibitors: Search for Potential Compounds

Recent Advances in the Treatment and Management of Alzheimer's Disease: A Precision Medicine Perspective

An exhaustive perspective on structural insights of SGLT2 inhibitors: A novel class of antidiabetic agent

Recent Advances in PI3 Kinase Inhibitors: Anticancer Activities and Structure-Activity Relationships

A Mini-review on Recent Strategies and Applications of Nanomedicines to Combat Antimicrobial Resistance

Current Insights into the Chemistry and Antitubercular Potential of Benzimidazole and Imidazole Derivatives

Recent Updates on Structural Aspects of ALK Inhibitors as an Anticancer Agent

The Recent Development of Piperazine and Piperidine Derivatives as Antipsychotic Agents

Practical Perspectives and Roles of XRD in Drug Discovery: A Review

Discovery of Novel Antimalarial Drugs Based on Thiosemicarbazone Derivatives: An In Silico Approach

Recent Updates on Indole Derivatives as Kinase Inhibitors in the Treatment of Cancer

Triggering PIK3CA Mutations in PI3K/Akt/mTOR Axis: Exploration of Newer Inhibitors and Rational Preventive Strategies

In silico-Based Structural Prediction, Molecular Docking and ADMET Analysis of Novel Imidazo-Quinoline Derivatives as Pf Purine Nucleoside Phosphorylase Inhibitors

Mutant B-Raf Kinase Inhibitors as Anticancer Agents

Integrated Computational Analysis on Some Indolo-quinoline Derivatives for the Development of Novel Antiplasmodium Agents: CoMFA, Pharmacophore Mapping, Molecular Docking and ADMET Studies

Perspectives of Anti-Cancer Phytoconstituents in Pharmacotherapy

In silico studies on pyrazine derivatives for identifying potential inhibitors of PIM-1 kinase

Chalcones and their therapeutic targets for the management of diabetes: Structural and pharmacological perspectives

Aktive Filter

Suchergebnisse filtern